Resonance Health Ltd has released a press release.
Appendix 4C - quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Resonance Health
- Resonance Health: HepaFat-AI Receives CE Marking
- HepaFat-AI Receives TGA Approval
- HepaFat-AI Incorporated into Blackford Analysis
- HepaFat-AI gains US FDA clearance
- New Pulmonary Embolism AI Solution Developed
Later from Resonance Health
- R&D Update - Molecular Medicine ASO Project
- Filing of Patent Application
- Resignation of CEO & Management Changes
- Appointment of Managing Director
- Appointment of GM - Global Sales & Marketing
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health